Angelini Pharma (as Angelini Group, with a 1.5 billion USD turnover) in Italy has a cGMP facility, inspected by US FDA since 1979, and by all international regulatory authorities.
It is specialized in Custom Synthesis of API’s and Advanced Intermediates, equipped with a Class C (10,000) Kilo Lab and four production units.
The Plant has 140,000 Lt glass lined and Stainless steel Reactor Capacity and a Pilot plant with 250-800 Lt reactor capacity.
A multipurpose Technology base, full Analytical services and support, blending and sieving are offered.
Angelini has recently installed Micro Flow reactors which increase yields, product quality, scalability and efficiency of chemical processing, reducing at the same time the performance variability and cost.